Cologne-based biotech start-up Disco Pharmaceuticals is taking a new approach to cancer therapy: using innovative ...
Seit Mai 2000 informiert das VentureCapital Magazin Investoren, innovative Unternehmer und Intermediäre über Trends, Transaktionen und Hintergründe rund um privates Beteiligungskapital, ...
Personalised cancer therapies have long been considered one of medicine’s most promising frontiers. Recent clinical results from Merck and Moderna involving mRNA-based approaches have added fresh ...
Every early-stage life sciences asset is heading towards the most regulated industry in the world. The process used to evaluate these as- sets, however, is rarely held to any comparable standard.
The landscape for radiopharmaceutical therapies in oncology is evolving rapidly, propelled by early commercial successes and ...
ESMT Berlin und KfW Capital haben ein Leadership-Programm entwickelt, das Fondsmanager sowie Kapitalgeber auf ihre Aufgaben ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results